Oppenheimer & Co’s ESSA Pharma EPIX Stock Holding History

Oppenheimer & Co’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-47,300	Closed	-$378K	–	1510
2021 Q3	$378K	Buy	+47,300	New	+$752K	0.01%	1127

Other funds holding EPIX

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Oppenheimer & Co's EPIX Position: Q4 2021 in Review

Oppenheimer & Co sold out of ESSA Pharma (EPIX) in Q4 2021, closing a stake of 47,300 shares — an estimated $378K sold.

Oppenheimer & Co first reported a position in EPIX in Q3 2021 and held it in 1 quarter. The position peaked at $378K in Q3 2021. 60 funds tracked by Wall St. Rank hold EPIX as of Q4 2021.

Oppenheimer & Co reported no remaining ESSA Pharma position as of Q4 2021 after selling out during the quarter.
Oppenheimer & Co sold 47,300 ESSA Pharma shares in Q4 2021, an estimated $378K.
Oppenheimer & Co first reported a position in ESSA Pharma in Q3 2021 and held it in 1 quarter.
Oppenheimer & Co's ESSA Pharma position peaked at $378K in Q3 2021.
60 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2021.

Based on Oppenheimer & Co's 13F filing for Q4 2021, filed 2 Feb 2022.